ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
US Tech 100
20,836.00
1.31%
Dow Jones
42,840.26
1.18%
Brent Oil
72.72
0.00%
Bitcoin
98,218.21
0.47%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Fortrea Holdings Inc (FTRE) Quote

Fortrea Holdings Inc

Fortrea Holdings Inc (FTRE)

NASDAQ
19.26
0.76
(4.11%)
Closed December 21 4:00PM
Delayed by 15 minutes
19.26
-0.02
(-0.10%)
After Hours: 7:59PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
19.26
Bid
16.57
Ask
20.68
Volume
2,653,833
18.35 Day's Range 19.53
16.53 52 Week Range 41.02
Market Cap
1.728B
Previous Close
18.50
Open
18.67
Last Trade
5
@
19.63
Last Trade Time
Financial Volume
$ 51,066,236
VWAP
19.2424
Average Volume (3m)
1,291,487
Shares Outstanding
89,700,000
Dividend Yield
-
PE Ratio
-508.18
Earnings Per Share (EPS)
-0.04
Revenue
3.11B
Net Profit
-3.4M

About Fortrea Holdings Inc

Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. It offers phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, bio... Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. It offers phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. is based in Durham, North Carolina. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
www.fortrea.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Fortrea Holdings Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker FTRE. The last closing price for Fortrea was $18.50. Over the last year, Fortrea shares have traded in a share price range of $ 16.53 to $ 41.02.

Fortrea currently has 89,700,000 shares outstanding. The market capitalization of Fortrea is $1.66 billion. Fortrea has a price to earnings ratio (PE ratio) of -508.18.

Ask ADVFN Intelligence (AI)

Fortrea (FTRE) Options Flow Summary

FTRE Options Flow

Overall Flow

Bullish

Net Premium

93k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

FTRE Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

December 17 2024
Edgar (US Regulatory)

Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors

SAN DIEGO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to...

December 05 2024
GlobeNewswire Inc.

Fortrea to Present at the Evercore HealthCONx Conference

DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike...

November 26 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 08 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 08 2024
Edgar (US Regulatory)

Fortrea Reports Third Quarter 2024 Results

For the three months ended September 30, 2024, from continuing operations: Revenues of $674.9 millionGAAP net loss of $(18.5) millionAdjusted EBITDA of $64.2 millionGAAP and adjusted net income...

November 08 2024
GlobeNewswire Inc.

Fortrea Releases Inaugural Corporate Social Responsibility Report

DURHAM, N.C., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the release of the company’s inaugural Corporate...

October 17 2024
GlobeNewswire Inc.

Fortrea Announces Date for Third Quarter 2024 Financial Results and Conference Call

DURHAM, N.C., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced that it will release its third...

October 14 2024
GlobeNewswire Inc.

Fortrea Reports Second Quarter 2024 Results

For the three months ended June 30, 2024, from continuing operations: Revenues of $662.4 millionGAAP net loss of $(99.3) millionAdjusted EBITDA of $55.2 millionGAAP and adjusted diluted loss per...

August 12 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.845-4.2029345933820.10520.8617.82108187219.34319623CS
4-0.24-1.2307692307719.525.0517.82122345421.29724239CS
12-0.72-3.603603603619.9825.2816.53129148720.05088647CS
26-4.44-18.734177215223.728.4116.53145615021.90827467CS
52-14.39-42.763744427933.6541.0216.53126057226.16547756CS
156-14.54-43.017751479333.841.0216.53140596428.02991359CS
260-14.54-43.017751479333.841.0216.53140596428.02991359CS

FTRE - Frequently Asked Questions (FAQ)

What is the current Fortrea share price?
The current share price of Fortrea is $ 19.26
How many Fortrea shares are in issue?
Fortrea has 89,700,000 shares in issue
What is the market cap of Fortrea?
The market capitalisation of Fortrea is USD 1.66B
What is the 1 year trading range for Fortrea share price?
Fortrea has traded in the range of $ 16.53 to $ 41.02 during the past year
What is the PE ratio of Fortrea?
The price to earnings ratio of Fortrea is -508.18
What is the cash to sales ratio of Fortrea?
The cash to sales ratio of Fortrea is 0.56
What is the reporting currency for Fortrea?
Fortrea reports financial results in USD
What is the latest annual turnover for Fortrea?
The latest annual turnover of Fortrea is USD 3.11B
What is the latest annual profit for Fortrea?
The latest annual profit of Fortrea is USD -3.4M
What is the registered address of Fortrea?
The registered address for Fortrea is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Fortrea website address?
The website address for Fortrea is www.fortrea.com
Which industry sector does Fortrea operate in?
Fortrea operates in the MEDICAL LABORATORIES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
$ 0.24
(65.06%)
354.32M
APTOAptose Biosciences Inc
$ 0.28
(64.51%)
305.1M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.606999
(6.49%)
292.16M
NVDANVIDIA Corporation
$ 134.70
(3.08%)
287.21M
PLTRPalantir Technologies Inc
$ 80.55
(8.54%)
277.63M

Discussion

View Full Feed
StayHumble StayHumble 5 minutes ago
💹💹💹 https://theqcup.com/patents
HCMC
StayHumble StayHumble 8 minutes ago
💹$HCMC Heading 2Court💹StrongerCase Sufficient 2Disavow $PM💹! @InsidePMI Self Reports of

Less Combustion = No Combustion

https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/6436df8d94fa09523deadf45/1681317773824/2023-04-12_HCMC_v_P
HCMC PM
capgain capgain 11 minutes ago
Do we know what was in the bill that passed last night?
StayHumble StayHumble 15 minutes ago
💹infinity incoming in SHORT Order💹Power2 the P1ayers💹💹💹
GME
CorsairNavigator20 CorsairNavigator20 20 minutes ago
What is your purpose on this board? This is a microcap not a large cap. If you are looking for dividends look at JEPQ an ETF that pays around 9% and it uses an .options strategy. Depends on your definition nice yield. Also I do take exception to the slobbering gambling addict since all stock mar
MRKR
hnbadger1 hnbadger1 23 minutes ago
The abstract of the patent application titled
"Therapy Selection and Treatment of Neurodegenerative Disorders" describes a method for individualized therapy selection and monitoring for neurodegenerative disorders. The focus is on using Sigma-1 receptor agonist therapy to treat neurodegenerat
AVXL
CanItBThisEZ2Make CanItBThisEZ2Make 25 minutes ago
BEST SELLERS RANK (BSR) IS 853 69 Estimated Sold on Amazon Since OCT 1 - 4TH Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec
SRMX
Frankestin Frankestin 29 minutes ago
the only weakness is the effect which is below average... I wrote previously... but they are average aspects in the sense that for some it is probably higher and for someone lower than average. The real question to which I cannot find an answer is: what cohen effect do the current remedies have?
TNXP
Wayne R Wayne R 33 minutes ago
Things got complicated since FINRA took charge.

Now companies can say, that is what we filed but that wasn't what we meant, after the fact.

Why they'd even bother with a 1 share roundup is a mystery, unless.., they don't like this company and want to make sure it gets d
VERB
capgain capgain 34 minutes ago
Please hurry!
edbi46 edbi46 38 minutes ago
Lets see how high our beloved BIEL gets TRUMPed/JFK JUNIORed/DR. OZed up by Jan. 1, before NOPAIN Act is activated ( and, specifically, after!!! ) !!!!!

No WORD SALADS, no SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS, ( for like 13 years, from Oct. 2011 and counting?? ), did/will do any d
MCF WBA
capgain capgain 39 minutes ago
Well, you have that right :)
marcis marcis 40 minutes ago
Bongu ☕️ Happy holidays 🎄

Saturday’s Cafe’ Chat.

$RDAR What market can this company capture or expand on?
It has $45 million, just announced this week, to start work with.

( maybe we should start a new chat board
Cafe
RDAR
glenn1919 glenn1919 43 minutes ago
LTRY.......................https://stockcharts.com/h-sc/ui?s=LTRY&p=W&b=5&g=0&id=p86431144783
LTRY
Wayne R Wayne R 47 minutes ago
Hey, come on by.

On the menu is lasagna with FIVE cheeses!!

I always make too much. It must be because of the genes passed down from my Hungarian grandmother.

She always had something cooking and ready to eat just in case someone came by and was hungry.
Mufaso Mufaso 47 minutes ago
No, VKTX doesn't have an agreement in place with anyone. Brian Lian has said that Viking will announce an agreement with someone by EOY although that could drag on a bit as Viking may have a bit more leverage now that CagriSema looks to be second rate.

I speculated that it is Bachem
VKTX
FanOfspringsteen FanOfspringsteen 55 minutes ago
Yesterday, though roughly 5 minutes before open market , the share price was shown down - 7.6% and -11% half an hour before. I don't know the reason why. 
IDCC
SkeBallLarry SkeBallLarry 56 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 57 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 58 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
prototype_101 prototype_101 59 minutes ago
this new article by Lebby p6-7 leads me to believe that LWLG has suitors despite Lebby desire to stay as standalone

Electro-optic polymers – a revolution in optical switching?

https://online.flippingbook.com/view/660560119/6/
LWLG
SkeBallLarry SkeBallLarry 1 hour ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
shoondale shoondale 1 hour ago
Beside criminality, what qualifications does the bribery felon possess that Johnston and Williams would eagerly anoint him the president of their MedeSol company and then beg the judge to allow him to serve time as their president rather than serve his time to the society he swindled?
https:
MGON
hnbadger1 hnbadger1 1 hour ago
It seems like Anavex has built a proprietary software and diagnostic toolkit for CNS diseases using blarcamesine. They give a patient drug and measure before/after genetic response. They can then diagnose or determine risk for developing CNS diseases.
PERSONALIZED MEDICINE for most CNS diseas
AVXL

Your Recent History

NASDAQ
FTRE
Fortrea
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads